Skip to main content
Our Journey
Our Technology
Pipeline
Leadership
Investors
Get in Touch
Presentations
Overview
Press Releases
Events
Presentations
Corporate Governance
Analyst Coverage
Stock Information
SEC Filings
Investor FAQs
Investor Contact
Loraine Spreen
+1-857-277-4842
loraine.spreen@kalarx.com
Presentations
Date
Title
Mar 16, 2021
Kala Pharmaceuticals Corporate Overview - March 2021
2.6 MB
Print Page
RSS Feeds
E-mail Alerts